Frequently Asked Questions
The market is segmented based on , By Type (Tracheobronchial Stents, Laryngeal Stents), Material (Metal Stents, Silicone Stents, Hybrid Stents), Product (Self-Expandable Stents, Non-Expandable Stents), End-User (Hospitals, Ambulatory Surgery Centers) – Industry Trends and Forecast to 2030.
.
The Global Lung Stent Market size was valued at USD 0.98 USD Billion in 2022.
The Global Lung Stent Market is projected to grow at a CAGR of 6% during the forecast period of 2023 to 2030.
The major players operating in the market include Thermo Fisher Scientific , Novartis AG, Abbott, Amgen , Johnson & Johnson Services , GlaxoSmithKline plc, Bayer AG, BD, Boston Scientific Corporation, Taewoong Medical Co Ltd, Micro,Tech Co Ltd, Novatech SA, E. Benson Hood Laboratories , Merit Medical Systems , Cook, EFER ENDOSCOPY, ENDO,FLEX GmbH, Standard Sci Tech , Stening SRL.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
